LATEST ARTICLES
BGU Scientists Duplicate Blood-Brain Barrier Outside the Body
Scientists can't make a living copy of your brain outside your body. That's the stuff of science fiction. But in a new study, they...
A new molecular mechanism could explain the origins of the depressive...
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of...
My Huntington’s disease sister – and a hero who strives for...
Sharon Shaffer is my Huntington’s disease sister – and my hero.
Afflicted with progressively worse HD symptoms the past 15 years, San Diego area resident...
UNIVERSITY
BGU Scientists Duplicate Blood-Brain Barrier Outside the Body
Scientists can't make a living copy of your brain outside your body. That's the stuff of science fiction. But in a new study, they...
A new molecular mechanism could explain the origins of the depressive...
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of...
Smartphone app can help diagnose a rare disease
Team of researchers at Kaunas University of Technology (KTU), Lithuania have created a mobile application, which helps recognise early symptoms of a rare Huntington’s...
Huntington drug successfully lowers levels of disease-causing protein
An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels...
HDBUZZ
Fresh Updates from First Huntingtin Lowering Study Publication
Hot off the presses - New publication gives more details about the results of Ionis and Roche's safety study with a Huntingtin-lowering ASO
oday saw...
An Updated Trial Design for Roche’s Huntingtin Lowering Trial
Roche announces an update to the GENERATION HD1 trial after reviewing the ASO open label extension study
Today we received word about a change to...
ARTICLES
IONIS-HTTRx
